Compare ABEO & ETHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ABEO | ETHM |
|---|---|---|
| Founded | 1974 | 2024 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 280.2M | 229.1M |
| IPO Year | 2005 | N/A |
| Metric | ABEO | ETHM |
|---|---|---|
| Price | $4.95 | $10.44 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $18.75 | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 97.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.74 | N/A |
| EPS | ★ 1.35 | N/A |
| Revenue | ★ $2,998,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1,589.77 | N/A |
| P/E Ratio | $3.53 | ★ N/A |
| Revenue Growth | ★ 258.18 | N/A |
| 52 Week Low | $3.93 | $10.24 |
| 52 Week High | $7.54 | $11.10 |
| Indicator | ABEO | ETHM |
|---|---|---|
| Relative Strength Index (RSI) | 46.91 | 70.64 |
| Support Level | $4.87 | $10.36 |
| Resistance Level | $5.60 | $10.46 |
| Average True Range (ATR) | 0.20 | 0.04 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 27.73 | 80.00 |
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
Dynamix Corp is a blank check company.